Stratagene to Present at the UBS Global Life Sciences Conference

Stratagene Corporation (NASDAQ:STGN) today announced
that it will present at the UBS Global Life Sciences Conference, which
will take place at the Grand Hyatt Hotel in New York City, on Tuesday,
September 26, 2006. The presentation, which is scheduled for 8:30 AM
Eastern Time, will include a review of the Company's business strategy
and historical financial results.
   A live audio-only webcast of the presentation will be broadcast
via the internet. Those interested in listening to the webcast will
find a link to the webcast registration page on Stratagene's website,
www.stratagene.com. An archived replay of the presentation will also
be available approximately one hour following the live presentation
and may be accessed at www.stratagene.com. It will be available for 90
days.

   About Stratagene Corporation

   Stratagene is a developer, manufacturer and marketer of
specialized life science research and diagnostic products. The
Company's life science research unit supports advances in science by
inventing, manufacturing and distributing products that simplify,
accelerate and improve research. These products are used throughout
the academic, industrial and government research sectors in fields
spanning molecular biology, genomics, proteomics, drug discovery and
toxicology. The Company's diagnostic unit develops and manufactures
products for urinalysis as well as high quality automated instrument
and reagent systems that use blood samples to test for more than 1,000
different allergies and autoimmune disorders. In addition, by
combining its expertise in diagnostics and molecular biology, as well
as its experience with FDA regulatory procedures, the Company is
pursuing opportunities to expand its product portfolio to include
molecular diagnostic kits and instrumentation. More information is
available at www.stratagene.com.